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Lipids are present within the cell nucleus, where they engage with
factors involved in gene regulation. Cholesterol associates with
chromatin in vivo and stimulates nucleosome packing in vitro, but
its effects on specific transcriptional responses are not clear. Here,
we show that the lipidated Wilms tumor 1 (WT1) transcriptional
corepressor, brain acid soluble protein 1 (BASP1), interacts with
cholesterol in the cell nucleus through a conserved cholesterol inter-
action motif. We demonstrate that BASP1 directly recruits cholesterol
to the promoter region of WT1 target genes. Mutation of BASP1 to
ablate its interaction with cholesterol or the treatment of cells with
drugs that block cholesterol biosynthesis inhibits the transcriptional
repressor function of BASP1. We find that the BASP1–cholesterol in-
teraction is required for BASP1-dependent chromatin remodeling and
the direction of transcription programs that control cell differentiation.
Our study uncovers a mechanism for gene-specific targeting of cho-
lesterol where it is required to mediate transcriptional repression.
BASP1 | WT1 | cholesterol | transcription | chromatin
It has been known for several decades that lipids and the en-zymes that regulate lipid metabolism are present in the nucleus
(1–3). The pool of nuclear lipids includes phospholipids, sphin-
golipids, gangliosides, and cholesterol that associate with nuclear
proteins, chromatin, and the recently described nuclear lipid droplets
(4). Several studies have reported that nuclear lipids associate with
components of the transcription machinery, but their function(s)
in gene regulation are not clear (1–3).
Brain acid soluble protein 1 (BASP1) is a transcriptional cofactor
that associates with Wilms tumor 1 (WT1), converting it from a
transcriptional activator to a repressor (5). Although BASP1 was
initially identified as a cytoplasmic protein enriched in neuronal
cells (6), it has since been found to be widely expressed and also
enters the nucleus through a functional nuclear localization se-
quence (NLS; Fig. 1A; 7). BASP1 is N-terminally myristoylated and
uses this motif to interact with membrane phospholipids within the
cytoplasm (8). BASP1 also contains a cholesterol recognition amino
acid consensus (CRAC) motif adjacent to its N-terminal myristoyl
moiety (Fig. 1A) that binds to cholesterol within cell membranes
(6, 9, 10). Thus, BASP1 can localize to cell membranes through
simultaneous interactions with phospholipids and cholesterol.
Previous studies have reported the binding of BASP1 to different
cholesterol species, including cholesterol esters and oxysterols (8),
which are also present within the nucleus (1). The N-terminal re-
gion of BASP1 containing the myristoyl motif, lipid-binding region,
and NLS is termed the effector domain (6, 8; sequence shown
in Fig. 1A). A similar effector domain is also found in GAP-43 and
myristoylated alanine rich protein kinase C substrate (MARCKS), but
outside this region, BASP1 shows no similarity to other proteins (6).
N-terminal myristoylation of BASP1 is also required for its func-
tion as a transcriptional repressor, and it uses this motif to interact
with and recruit phosphatidylinositol 4,5-bisphosphate (PIP2) to gene
promoters (11, 12). The promoter-bound BASP1–PIP2 complex
supports the assembly of chromatin remodeling proteins, including
histone deacetylase 1 (HDAC1) and Brahma-related gene 1 (BRG1),
to WT1 target genes (11, 12). BASP1 can also repress the function
of other transcriptional activators, including c-myc (13, 14) and
estrogen receptor α (15), suggesting a broad role for this lipidated
cofactor in the regulation of transcription.
WT1 and BASP1 cooperate to drive transcriptional programs
that control differentiation in several model cell line systems (7, 11,
12, 16–18). Recent studies in mice found that knockout of BASP1
in taste receptor cells leads to loss of differentiated phenotype and
the reactivation of WT1 target genes that are normally associated
with the progenitor cells (19). A fundamental role for WT1-BASP1
in promoting the differentiated state is demonstrated by the finding
that depletion of BASP1 in adult fibroblasts replaces the require-
ment of SOX2, c-Myc, or OCT4 in the induction of fibroblasts to
pluripotency (20). In these cells, BASP1 normally represses WT1
target genes and blocks pluripotency in favor of cell maintenance in
their differentiated state.
As mentioned above, BASP1 contains a functional CRAC motif
adjacent to its N-terminal myristoyl moiety and binds to both
cholesterol and PIP2 within cell membranes (9, 10; Fig. 1A). In
this study, we demonstrate that BASP1 interacts with cholesterol via
its CRACmotif within the cell nucleus, recruiting it to the promoter
region of WT1 target genes. We find that the BASP1–cholesterol
interaction is required for transcriptional repression and that it plays
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a role in BASP1-dependent differentiation in vitro. Our results
demonstrate direct gene-specific control by cholesterol through
interaction with the lipidated transcriptional repressor BASP1.
Results
BASP1 Interacts With Cholesterol in the Cell Nucleus through a Conserved
CRAC Motif.BASP1 interacts with cholesterol-rich domains (6, 8–10)
and contains a conserved CRAC motif [L/V-X(1-5)-Y-X(1-5)-R/K]
located within the N terminus close to the myristoyl motif (21; Fig. 1A).
Using Escherichia coli engineered to express N-myristoyl trans-
ferase (NMT), we generated recombinant myristoylated wild-type
(wt) BASP1 containing a carboxyl-terminal His-tag (myrBASP1)
and the myristoylated mutant derivative Y12L (myrBASP1 Y12)
that ablates the critical tyrosine residue of the CRAC motif. We
also expressed the same proteins in E. coli lacking NMT to pro-
duce nonmyristoylated wtBASP1 and BASP1 Y12L. The purified
proteins are shown in Fig. 1B. In filter binding assays, recombi-
nant myristoylated wtBASP1 bound directly to cholesterol, but
the nonmyristoylated forms of BASP1 did not. Moreover, the
interaction of myristoylated BASP1-Y12L with cholesterol was
significantly reduced (Fig. 1B; see quantitation below). Thus,
both myristoylation of BASP1 and an intact CRAC motif are
required for its direct interaction with cholesterol.
Our previous work has used K562 chronic myelogenous leukemia
cells, which lack endogenous BASP1 but contain endogenous WT1.
Stably introducing wtBASP1 into K562 cells (B-K562) represses
WT1-dependent target genes compared to vector control K562
cells (V-K562; 7, 11, 12, 16). We generated a K562 cell line deriv-
ative that expresses BASP1-Y12L (Y-K562), which, like wtBASP1,
is largely nuclear (SI Appendix, Fig. S1A). Immunoprecipitation of
BASP1 from nuclear extracts via a carboxyl-terminal HA-tag fol-
lowed by dot blotting to detect PIP2 confirmed that both wtBASP1
and BASP1 Y12L bind PIP2 (SI Appendix, S1B; 11, 12). BASP1
Y12L also coimmunoprecipitated with WT1 (Fig. 1C) and HDAC1
(Fig. 1D) from nuclear extracts at a level comparable with
wtBASP1. Thus, the interaction of BASP1 with WT1, HDAC1, and
PIP2 does not depend on an intact CRAC motif within BASP1,
suggesting that these contacts do not require cholesterol.
We next sought to determine if BASP1 interacts with cholesterol
in the cell nucleus. To resolve nuclear cholesterol from cytoplasmic
cholesterol, we isolated nuclei with low cytoplasmic contamination
as determined by levels of the Golgi protein TGN46 (SI Appendix,
Fig. S1C) and the endoplasmic reticulum (ER) marker calreticulin
(SI Appendix, Fig. S1D). The K562 cell line derivatives were incu-
bated in lipid-free media supplemented with a 27-alkyne cholesterol
derivative that is utilized by cells as standard cholesterol (22). Nuclei
were then prepared and, using click chemistry, the 27-alkyne
cholesterol was cross-linked to azide-PEG3-biotin, which was then
detected using a streptavidin-linked fluorophore. BASP1 was
simultaneously probed using immunocytochemistry. Cholesterol
was detected within the purified nuclei of K562 cells (Fig. 2A;
cholesterol [CHO]) and showed reduced colocalization with BASP1-
Y12L compared to wtBASP1 (Manders quantitation of the pro-
portion of BASP1 signal that overlaps with cholesterol is shown
below, Left). Endogenous BASP1 in MCF7 cells also colocalized
with 27-alkyne cholesterol within the nucleus (Fig. 2B). Moreover,
the nuclear 27-alkyne cholesterol signal in MCF7 cells was re-
duced when BASP1 expression was knocked down by short hair-
pin RNA (shRNA). We next used click chemistry combined with
immunoprecipitation to test the interaction between BASP1 and
nuclear cholesterol. V-K562, B-K562, and Y-K562 cells were
cultured with 27-alkyne cholesterol as above for 48 h (as above)
and then underwent the click chemistry reaction with azide-PEG3-
biotin. Nuclear protein extracts were prepared followed by precip-
itation with streptavidin-coated beads. wtBASP1, but not BASP1-
Y12L, coprecipitated with alkyne cholesterol (Fig. 2C). Similar
analysis verified that 27-alkyne cholesterol associates with en-
dogenous BASP1 in the nuclei of MCF7 cells (Fig. 2D). Taken
together, the data in Fig. 2 demonstrate that BASP1 interacts
with nuclear cholesterol via a functional CRAC motif.
BASP1 Recruits Cholesterol to the Gene Promoter Region of WT1 Target
Genes. We next investigated whether an intact CRAC motif in
BASP1 is required for transcriptional repression. As we have
previously shown, wtBASP1 repressed transcription of the WT1
target genes AREG, ETS-1, JUNB, and VDR (7, 11, 12; Fig. 3A).




Fig. 1. BASP1 interacts with cholesterol via a CRAC motif. (A) Schematic of
BASP1with N-terminal myristoyl (red), NLS, and PESTmotifs. The N-terminal 25
residues—myristoylated G2 (red), PIP2-binding domain, bipartite NLS, and
CRAC motif (central Tyr underlined in green)—are below. (B) Myristoylated
and nonmyristoylated wtBASP1 or BASP1-Y12L prepared from E. coli (Coomassie
gel at Left) were used to probe membranes dot blotted with cholesterol
(0.04, 0.2, and 1 nmol). + is a positive control for BASP1 binding (sheep BASP1
antibody). Ctrl is a membrane probed with BSA, while the other panels were
probed with the BASP1 derivatives and detected with rabbit BASP1 antibody.
ImageJ quantitation of the relative signal in the dot blots is below for three
independent experiments. Error bars are SDM of three independent experi-
ments. *** is Student’s t test P < 0.001. (C) Control IgG (αCtrl) or WT1 (αWT1)
antibodies were used for immunoprecipitation with nuclear extracts derived
from B-K562 or Y-K562 cells and the content probed for BASP1 by immuno-
blot. Input is 5% of the nuclear extract used in each immunoprecipitation. (D)
Control (αCtrl) or HA (αHA) antibodies were used for BASP1 immunoprecipitation
with nuclear extracts derived from B-K562 or Y-K562 cells and the content
probed for BASP1 or HDAC1 by immunoblot. Input is 5% of the nuclear
extract used in each immunoprecipitation.
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Chromatin immunoprecipitation (ChIP) analysis determined that
both wtBASP1 and BASP1 Y12L were recruited to the promoter
region of all the genes tested (Fig. 3B). Combining click chemistry
with ChIP (Click-ChIP), we found that cholesterol associates with
the AREG, ETS-1, JUNB, and VDR promoters at a significantly
increased level when wtBASP1 is also present at the promoter
(Fig. 3C; compare V-K562 with B-K562). In K562 cells that ex-
press BASP1-Y12L, cholesterol was recruited at a significantly
BA
C D
Fig. 2. BASP1 interacts with nuclear cholesterol. (A) K562 cell derivatives were incubated with 10 mg/mL alkyne cholesterol (CHO) in lipid-free media for 20 h.
Nuclei were purified and, after treatment with azide PEG3-biotin and click reaction using 2 mM CuBF4, subjected to immunocytochemistry with streptavidin-
linked fluorophore (CHO) or BASP1 antibodies. Scale bar is 5 μm. Below Right, cells treated in the same way, but without CHO-alkyne. Manders analysis to
quantitate the colocalization of cholesterol with wtBASP1 and BASP1-Y12L (Below, Left). Error bars are SDM of three independent experiments (n = 35 for
each condition). * is Student’s t test P < 0.05. (B) MCF7 cells stably expressing a control shRNA (shNEG) or shRNA targeting BASP1 (shBASP1) were used to
prepare nuclear extracts and immunoblotted with BASP1 or b-actin antibodies. Below, shNEG and shBASP1 MCF7 cells were incubated in lipid-free media with
10 μg/mL alkyne cholesterol. Nuclei were prepared followed by click chemistry and immunofluorescence with BASP1 antibodies and streptavidin antibodies to
detect nuclear cholesterol (CHO). Scale bars are 10 μm. At Right are control immunofluorescence performed with nuclei purified from cells that were not
incubated with alkyne cholesterol. (C) As in A, but nuclear extract was prepared and precipitation performed with streptavidin magnetic beads, then
immunoblotted with BASP1 or actin antibodies. −alkyne control IP is the same click chemistry reaction but with cells not incubated with alkyne cholesterol. (D)
MCF7 cells were incubated with (+) or without (−) alkyne cholesterol, nuclear extract was prepared followed by click chemistry, and the alkyne cholesterol was
captured with streptavidin magnetic beads. The content was probed with BASP1 or β-actin antibodies. Input is 5% of the nuclear extract used in each assay.
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reduced level at the AREG, JUNB, and VDR promoters com-
pared to B-K562 cells and, although not statistically significant,
was also reduced at the ETS-1 promoter. Thus, BASP1 recruits
cholesterol to the promoter region of WT1 target genes, and this
requires an intact CRAC motif in BASP1.
The BASP1–Cholesterol Interaction Is Required for the Control of
Differentiation. A central function of the WT1–BASP1 complex is
to drive cell differentiation programs (5). BASP1 cooperates with
WT1 to divert the phorbol ester–induced differentiation program
of K562 cells away from megakaryocytes to neuronal-like cells in
both morphology and function (7, 11, 12). This was driven by the
WT1/BASP1-dependent down-regulation of genes that specify
megakaryocyte identity accompanied by the up-regulation of
neuronal markers. We tested whether BASP1 Y12L was able to
support the neuronal-like differentiation program of K562 cells.
The K562 cell derivatives were induced to differentiate with
phorbol 12-myristate 13-acetate (PMA) for 72 h, and the extent of
cellular arborization was visualized by phase microscopy (Fig. 4A,
quantitation shown below). wtBASP1 expression in K562 cells led
to induction of an arborized phenotype compared to V-K562 cells,
and that arborization was significantly reduced in Y-K562 cells.
Analysis of the level of messenger RNA (mRNA) encoding
the megakaryocyte-specific markers DAB2 and ITGA2 revealed
that, whereas wtBASP1 blocked their induction (as we previously
reported in ref. 7), BASP1 Y12L failed to repress transcription
of DAB2 and was defective in repression of ITGA2 (Fig. 4B).
Analysis of neuronal-specific markers (MAO-A and ENC1)
showed that BASP1 induced their expression as we previously
reported (Fig. 4C; 7). BASP1 Y12L was defective in inducing MAO-A
but still able to support induction of ENC1. These data suggest
that BASP1 Y12L is selective in its effects in diverting the PMA-
induced K562 cell differentiation program to neuronal-like cells.
We next measured the ability of the PMA-treated cells to respond
to the neurotransmitter adenosine triphosphate (ATP). In agree-
ment with our earlier work (7), none of the control V-K562 cells
generated a Ca2+ signal in response to ATP, while 100% of the
B-K562 cells responded (19 of 19 cells tested; Fig. 4D, Left).
Y-K562 cells showed an intermediate response rate (60%; 12 of 20
cells tested). We then analyzed the Ca2+ signals of the cells that
responded to ATP. Comparisons of the peak amplitude of the
measured responses in the B-K562 and Y-K562 cells found the
size of the Ca2+signals in BASP1 Y12L cells were significantly
reduced compared to wtBASP1 cells, suggesting the Y-K562 cells
are less responsive to ATP (Fig. 4D, Right). Thus, the CRACmotif
in BASP1 plays a role in the diversion of the differentiation pro-
gram of K562 cells to a neuronal-like cell.
Inhibition of Cholesterol Synthesis Abolishes Transcriptional Repression
by BASP1. Our results so far have shown that mutation of the
critical tyrosine residue of the BASP1 CRAC motif disrupts the
interaction with cholesterol and its recruitment to the promoter
and causes a defect in transcriptional repression and BASP1-
induced differentiation. To confirm and extend these findings,
we determined the effect of cholesterol-depleting drugs on BASP1
function. We first confirmed that the drugs were used at an ef-
fective concentration to significantly reduce nuclear cholesterol
(SI Appendix, Fig. S2A). We treated V-K562 cells or B-K562 cells
with atorvastatin, an inhibitor of HMG-CoA reductase (the rate-
limiting enzyme in cholesterol biosynthesis) and determined the
effect on BASP1-mediated transcriptional repression. Atorvasta-
tin treatment abolished transcriptional repression of AREG and
ETS-1 by BASP1 in K562 cells (Fig. 5A). Similar experiments with
lovastatin (which also inhibits HMG-CoA reductase) produced
comparable results (SI Appendix, Fig. S2B). We also tested the ef-
fect of atorvastatin on BASP1 transcriptional repressor function in
MCF7 cells transiently transfected with either a control small in-
terfering RNA (siRNA) or siRNA targeting BASP1. Knockdown
of endogenous BASP1 in MCF7 cells led to relief of repression of
WT1 target genes as previously reported (Fig. 5B; 12). When the
cells were treated with atorvastatin, the relief of transcriptional
repression upon BASP1 knockdown did not occur. We observed
similar effects when MCF7 cell line derivatives that stably express
either a control shRNA (shNEG) or BASP1 shRNA (shBASP1),
targeting a different sequence to the siRNA used in Fig. 5B), were
treated with lovastatin (SI Appendix, Fig. S2C). Statins inhibit
the biosynthesis of both cholesterol and isoprenoids (23). We
therefore next tested the effect of triparanol, an inhibitor of
24-dehydrocholesterol reductase, which catalyzes the final step in
cholesterol biosynthesis pathway and does not inhibit isoprenoid
production. As we had observed with the statins, triparanol
blocked the transcriptional repressor function of BASP1 (Fig. 5C).
We next determined whether interference with cholesterol bio-
synthesis in K562 cells affects the BASP1-dependent differentia-
tion to neuronal-like cells. As before, treatment of B-K562 cells,
but not V-K562 cells, with PMA induced an arborized phenotype
(Fig. 5D). This was blocked if the cells were simultaneously
treated with atorvastatin (see quantitation below). To confirm that
the effect of atorvastatin on the differentiation of B-K562 cells was
due to reduced cholesterol availability, we determined whether its
effects could be reversed by the coaddition of cholesterol to the
cell culture media. We used an established protocol that solubi-
lizes cholesterol with methyl-β-cyclodextrin (MβCD) at levels that
lead to cellular accumulation of cholesterol (24). Addition of
cholesterol through this method led to the PMA-induced arbori-
zation of the B-K562 cells even when atorvastatin was present in
the media (Fig. 5E; quantitation shown at Right. Images of the
V-K562 cells are shown in SI Appendix, Fig. S2D). Taken together,
the data in Fig. 5 demonstrate that inhibition of cholesterol bio-
synthesis blocks the transcriptional repressor function of BASP1
and impedes BASP1-induced differentiation.
The BASP1–Cholesterol Interaction Is Required for Chromatin Remodeling.
BASP1 acts as a transcriptional repressor by remodeling chromatin
and blocking the recruitment of RNA polymerase II (Pol II) at
the promoter region of WT1 target genes (11, 12, 17). We next
performed ChIP analysis with the K562 cell line derivatives to
determine the effect of wtBASP1 and BASP1-Y12L on Pol II
recruitment as well as two histone modifications indicative of
transcriptional activity (H3K9Ac and H3K4me3) at the AREG
and ETS-1 promoters (Fig. 6A). Compared to V-K562 cells, B-K562
cells show significantly reduced H3K9Ac, reduced H3K4me3, and
reduced Pol II binding at the AREG and ETS-1 promoters.
BASP1 Y12L did not support the reduction in either the active
chromatin marks or in Pol II recruitment. Indeed, there was a
significant increase over the vector control cells, suggesting the
possibility that BASP1 Y12L has transcriptional activator prop-
erties. We next performed ChIP analysis using MCF7 cell line
derivatives that express either a control shRNA (shNEG MCF7)
or an shRNA that targets BASP1 (shBASP1) to determine the
effect of atorvastatin on H3K9Ac and H3K4me3 marks at the
ETS-1 promoter. Consistent with the observations in K562 cells,
shRNA-mediated knockdown of BASP1 in MCF7 cells caused an
increase in H3K9Ac and H3K4me3 marks at the ETS-1 promoter
(Fig. 6B). However, treatment of the MCF7 cell line derivatives
with atorvastatin abolished the BASP1-dependent changes in
these marks. We note that atorvastatin treatment caused a general
increase in H3K9 acetylation and to a lesser extent H3K4 trime-
thylation, suggesting that it also elicits BASP1-independent func-
tions on these histone modifications. Taken together, the data in
Fig. 6 A and B suggest that the BASP1–cholesterol interaction is
required for BASP1-dependent histone modification.
Our previous work has shown that BASP1 interacts with HDAC1
to deacetylate H3K9 (11). BASP1 Y12L coimmunoprecipitated with
HDAC1 from nuclear extracts at a level similar to wtBASP1 (Fig. 1D).
Consistent with this, we also found that BASP1 Y12L recruited
4 of 11 | PNAS Loats et al.





















HDAC1 to the promoter region of the AREG and ETS-1 genes to a
level similar to wtBASP1 (Fig. 6C). Furthermore, treatment of B-K562
cells with atorvastatin did not significantly affect HDAC1 recruitment
at the ETS-1 promoter (Fig. 6D). Thus, the BASP1–cholesterol
interaction is not required for HDAC1 recruitment but is required
for both the deacetylation of H3K9 and demethylation of H3K4.
B CA
Fig. 3. BASP1 Y12L is defective in transcriptional repression and fails to recruit cholesterol to the promoter of WT1 target genes. (A) cDNA was prepared
from V-K562, B-K562, or Y-K562 cells. Expression of AREG, ETS-1, JUNB and VDR were compared to control GAPDH. (B) Cells as above were subjected to ChIP
analysis with αBASP1 or control (αCtrl) IgG. Presented as fold enrichment over a control genomic region. (C) K562 cell lines were incubated with alkyne cholesterol
as in Fig. 1E. After the click chemistry reaction, the cells were subjected to ChIP with streptavidin-linked beads (Click-ChIP). Results are fold enrichment over a
control genomic region. Error bars are SDM from at least three independent experiments. Student’s t test; *<0.05, **<0.01, ***<0.001, not significant (NS).
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Previous studies have identified several genes in the cholesterol
biosynthesis and lipid transport pathways as direct targets of WT1
(25, 26). Since BASP1 is a general repressor of WT1 transcription
function, we sought to determine whether an intact BASP1 CRAC
motif is required for transcriptional repression of a cohort of WT1
target genes identified from these previous studies connecting WT1
with cholesterol homeostasis. In K562 cells, wtBASP1, but not BASP1
Y12L, repressed transcription of key components of the mevalonate
pathway including FDFT1, FDPS, and IDI1 and the lipoprotein re-
ceptors LRP1 and VLDLR (five of the seven WT1 target genes
tested; Fig. 6E).
Discussion
In this study, we provide evidence for the directed recruitment of
cholesterol to gene promoters by BASP1 and show that choles-





Fig. 4. An intact CRAC motif in BASP1 is required to induce a neuronal-like differentiation program in K562 cells. (A) V-K562, B-K562, or Y-K562 cells were
treated with 200 nM PMA or DMSO for 72 h and then observed by phase microscopy. Percentage arborized cells is below. Error bars are SDM of three in-
dependent experiments and ** indicates Student’s t test P < 0.01. (B) Cells were treated as in A, but 48 h later, cDNA was prepared and qPCR used to de-
termine expression of the megakaryocyte markers DAB2 and ITGA2 relative to GAPDH. Error bars are SDM of three independent experiments with Student’s
t test; *P < 0.05, **P < 0.01, ***P < 0.001. (C) As in B, except that neuronal markers MAO-A and ENC1 were analyzed. (D). The K562 derivatives were treated as
in A, ATP (10 mM) was applied, and calcium responses were measured by fluorescence imaging. At Left, the percentage of cells that generated a calcium
signal to ATP. * indicates χ2 test at P < 0.01. At Right, the responsive B-K562 cells (n = 19 cells) and Y-K562 cells (n = 12 cells) are shown as a scatter plot against
the amplitude of response. * indicates P < 0.05 by Student’s t test.
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transcriptional repression. Previous studies found that the BASP1–
PIP2 interaction is required to mediate contact between BASP1
and HDAC1 (11). We determined that the BASP1–PIP2 inter-
action is not dependent on the BASP1 CRAC motif and, con-
sistent with this, BASP1 Y12L also interacts with HDAC1. Thus,
the BASP1–HDAC1 interaction is not dependent on cholesterol,
identifying distinct roles for PIP2 and cholesterol on BASP1
function as a transcriptional corepressor.
It is possible that the BASP1–cholesterol interaction facilitates
the recruitment of other chromatin remodeling complexes that
are a prerequisite for the action of HDAC1 at the promoter.






Fig. 5. Statins specifically inhibit the transcriptional repressor function of BASP1. (A) V-K562 or B-K562 cells were treated with 20 μM atorvastatin or drug
vehicle (DMSO) for 48 h. cDNA was prepared, and expression of AREG and ETS-1 was determined relative to GAPDH. At Right, a Western blot of BASP1 is
shown. (B) MCF7 cells were transfected with either a control siRNA (siNEG) or siRNA targeting BASP1 (siBASP1). 24 h later, the cells were treated with 20 μM
atorvastatin or drug vehicle (DMSO) for 48 h. cDNA was prepared, and expression of AREG and ETS-1 was determined relative to GAPDH. At Right, a Western
blot of BASP1 is shown. (C) As in A, except that cells were treated with 20 μM triparanol. (D) V-K562 cells or B-K562 cells were treated with PMA (200 nM) and/
or atorvastatin (20μM) as indicated. 72 h later, the cells were analyzed as in Fig. 4A. Percentage arborized cells is below (error bars are SDM of three in-
dependent experiments, and * indicates Student’s t test P < 0.05.) (E) As in D, except that cholesterol was also added to the media (100 μM) where indicated.
Percentage arborized cells is at Right (error bars are SDM of four independent experiments, and ** indicates Student’s t test P < 0.01). Graph also includes
quantitation from similarly treated V-K562 cells (images shown in SI Appendix, Fig. S2D).
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Fig. 6. A role for cholesterol in BASP1-dependent chromatin remodeling and cholesterol homeostasis. (A) ChIP was performed with V-K562, B-K562, and
Y-K562 cells with control IgG (αCtrl), H3K9Ac, H3K4me3, and RNA Pol II antibodies. Data are presented as fold enrichment at the AREG (Top) and ETS-1
(Bottom) promoters over a control genomic region. (B) MCF7 cells stably expressing either control shRNA (shNEG) or BASP1 shRNA (shBASP1) were treated
with 20 μM atorvastatin or vehicle (DMSO). 48 h later, the cells were cross-linked, and ChIP was performed with antibodies against H3K9ac (Top graph) or
H3K4me3 (Bottom graph) alongside IgG control (αCtrl). Data are presented as fold enrichment at the ETS-1 promoter against a control genomic region. Error
bars are SDM of at least three independent experiments (*P < 0.05 and **P < 0.01, and NS is not significant by Student’s t test). (C) ChIP was performed with
V-K562, B-K562, and Y-K562 cells with control IgG (α-Ctrl) or HDAC1 (α-HDAC1) antibodies. Data are presented as fold enrichment at the AREG (Top) and ETS-1
(Bottom) promoters compared to a control genomic region. (D) V-K562 or B-K562 cells were treated with 20 μM atorvastatin or vehicle (DMSO). 48 h later, the
cells were cross-linked, and ChIP was performed with antibodies against HDAC1 (α-HDAC1) or control (α-Ctrl) antibodies. Data are presented as fold en-
richment at the ETS-1 promoter against a control genomic region. Error bars denote SDM of at least three independent experiments (*P < 0.05, **P < 0.01,
***P < 0.001 by Student’s t test). (E) cDNA was prepared from V-K562, B-K562, or Y-K562 cells. Expression of the indicated genes was compared to control
GAPDH. Error bars denote SDM of four independent experiments (*P < 0.05, **P < 0.01 by Student’s t test).
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demethylase LSD1 within the CoREST complex are interdepen-
dent (27). Moreover, the activity of class I HDACs within different
complexes exhibit distinct specificities of action (28). It is therefore
possible that the lack of HDAC1-mediated H3K9 deacetylation in
Y-K562 cells is due to the failure of BASP1 Y12L to recruit other
chromatin remodeling factors that have yet to be identified.
Alternatively, cholesterol might be required to facilitate nucle-
osome modification through direct effects on chromatin. Previous
work has reported that cholesterol binds directly to histones and
drives the compaction of nucleosomes in vitro (2, 29). Cholesterol
interacts with at least six sites on the nucleosome and is proposed
to facilitate dewetting of hydrophobic surfaces on the histones,
leading to enhanced histone–histone contacts that drive chromatin
condensation. Thus, BASP1-mediated recruitment of cholesterol
might elicit direct effects on the nucleosome that contribute to
establishing transcriptionally repressive condensed chromatin at
specific genes. Further studies are needed to address this question.
A role for lipids in regulating the affinity and/or specificity of
protein–protein interactions in transcription regulation is remi-
niscent of the action of lipid-derived hormones on steroid receptor
transcription factors (30). However, the widely reported roles of
nuclear lipids in transcription suggest a more general function in
transcription control. The regulation of transcription by lipids
might also have additional physiological importance. Knockout of
WT1 in adult mice leads to rapid fat loss through direct effects on
adipocyte homeostasis and lipid metabolism (31). Indeed, several
genes in the cholesterol biosynthesis pathway and lipid transport
are target genes of WT1 (25, 26). We find that BASP1 represses
transcription of several of these WT1 target genes and that this is
dependent on an intact CRAC motif in BASP1. These results
suggest that the control of WT1-BASP1 by lipids provides a
feedback mechanism to regulate lipid metabolism.
Our data suggest that either BASP1 associates with cholesterol
in the cytoplasm and then moves to the nucleus or that it first
associates with cholesterol that is already present within the nu-
cleus. How lipids are sequestered within the nucleus and the
regulation of their subnuclear localization is not yet clear, but
lipidated transcription factors such as BASP1 can provide at least
part of the mechanism. Nuclear lipid droplets (NLDs) have re-
cently been described that may play a role in the regulation of
transcription factor accessibility (4, 32, 33). BASP1 is a component
of cytoplasmic cholesterol-rich lipid droplets (34), which raises the
prospect that BASP1 might also be incorporated into cholesterol-
rich NLDs. NLDs associate with promyelocytic leukemia bodies
(35), which can also contain BASP1 (18). It is therefore possible
that BASP1–lipid interactions may control transcription processes
through the formation of phase-separated nuclear bodies (36).
Lipidated transcription factors like BASP1 have the potential to
play important roles in liquid-liquid phase separation in chromatin
remodeling and transcription control (37, 38).
Materials and Methods
DNA Constructs. pcDNA3 BASP1-HA is described in Goodfellow et al. (7).
pcDNA3-BASP1 Y12L-HA was generated using the Quickchange site-directed
mutagenesis kit (Agilent, 200518) and verified by DNA sequencing. The
coding sequence of wtBASP1 and BASP1-Y12L lacking the stop codon was
amplified and cloned in frame into the NcoI/XbaI sites of pET23d bacterial
expression vector to generate BASP1 and BASP1-Y12L with a carboxyl-
terminal His-tag. pRSF-1-NMT for expression of N-myristoyl transferase in
bacteria was purchased from Addgene (42578).
Cell Lines, Transfection, and Antibodies. K562 cells were maintained in Roswell
Park Memorial Institute (RPMI) 1640 (Thermo Fisher, 11875101) supplemented
with 10% (vol/vol) fetal calf serum (Sigma-Aldrich, F9665), 1% (vol/vol)
penicillin–streptomycin (Pen-Strep) (Sigma-Aldrich, P4333), and 1% (vol/vol)
L-glutamine (Sigma-Aldrich, G7513). MCF7 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) (Thermo Fisher, 11960044) supplemented
with 10% (vol/vol) fetal calf serum and 1% (vol/vol) Pen-Strep. Stably trans-
fected K562 andMCF7 cell lines were additionally supplemented with 1 mg/mL
G-418 (Sigma-Aldrich, A1720). All cells were kept at 37 °C in humidified 95%
air and 5% CO2 atmosphere. Cells were transfected with plasmids using
Effectene (Qiagen, 301425) and with siRNA using HiPerFect (Qiagen, 301704).
Antibodies used are listed in SI Appendix, Table S1. For cell treatments, ator-
vastatin (Sigma-Aldrich, PZ0001), lovastatin (Sigma-Aldrich, M2147), triparanol
(Sigma-Aldrich, T5200), and phorbol 12-myristyl 3-acetate (PMA; Sigma-Aldrich,
524400) were dissolved in dimethyl sulfoxide (DMSO) and added to the cell
culture media at the concentrations indicated in the figure legends. Addition
of cholesterol to cell culture media was as described by Weidenmaier et al.
(24). Cholesterol (Sigma-Aldrich, C8667; dissolved in ethanol) was added to
methyl-β-cyclodextrin (MβCD, Sigma-Aldrich, C4555) dissolved in water to a
final concentration of 5 mM cholesterol/42 mg/mL MβCD. This was added to
cell culture media at a final concentration of 100 μM cholesterol.
Chromatin Immunoprecipitation. K562 cells were collected and resuspended to
a density of 1 × 106 cells/mL in phosphate buffered saline (PBS). Cross-linking
was achieved by adding formaldehyde to a final concentration of 1.42%
(vol/vol) and incubating at room temperature for 15 min. Formaldehyde was
quenched with ice-cold 125 mM glycine for 5 min at room temperature. Cells
were collected by centrifugation at 2,000 × g for 5 min at 4 °C and washed
with ice-cold PBS. Cells were resuspended to a concentration of 1 × 107
cells/mL and lysed in 1 mL immunoprecipitation (IP) buffer [150 mM NaCl,
50 mM Tris·HCl (pH 7.5), 5 mM ethylenediamine tetraacetic acid (EDTA),
0.5% (vol/vol) Nonidet P-40, and 1% (vol/vol) Triton X-100] plus protease
inhibitor mixture for 15 min on ice. Lysed samples were centrifuged at
2,000 × g for 5 min at 4 °C, and the pellet resuspended in 1 mL IP buffer plus
protease inhibitors for sonication. Chromatin was sheared via sonication
using a QSonica Q500 at 60% amplitude. Successful sonication giving fragments
200 to 500 bp in length was confirmed by resolving a small (de-cross-linked)
sample on a 1.5% (wt/vol) agarose gel. Following sonication, the lysate was
cleared by centrifugation at 12,000 × g for 10 min at 4 °C. Samples were
precleared by incubating with 10 μL Protein G magnetic beads (Thermo
Fisher, 88847) for 1 h, rotating at 4 °C. Five μL Protein G magnetic beads,
600 μL IP buffer, 1 μL 10 mg/mL acetylated bovine serum albumin (BSA), and
appropriate antibody were also incubated together in one microtube per
desired chromatin immunoprecipitation for a minimum of 4 h, rotating at
4 °C. 200 μL of precleared chromatin was then added to the incubated
microtube of antibody and beads and rotated at 4 °C overnight. A 2% input
sample was also stored for later de-cross-linking and processing.
Immunoprecipitated samples were then magnetized, supernatant was
discarded, and beads were sequentially washed once in IP buffer, high-salt IP
buffer [500 mM NaCl, 50 mM Tris·HCl (pH 8.0), 5 mM EDTA, 0.5% (vol/vol)
Nonidet P-40, 1% (vol/vol) Triton × 100], LiCl buffer [10 mM Tris·HCl (pH 8.0),
250 mM LiCl, 1 mM EDTA, 1% (vol/vol) Nonidet P-40, 1% (wt/vol) sodium
deoxycholate], and Tris-EDTA (TE) buffer [10 mM Tris·HCl (pH 8.0), 1 mM
EDTA]. After the final wash, beads and 2% input samples were resuspended
in 100 μL of proteinase K (PK) buffer [125 mM Tris·HCl (pH 8.0), 10 mM EDTA,
150 mM NaCl, 1% (wt/vol) sodium dodecyl sulfate (SDS)] and placed at 65 °C
overnight. Samples were then incubated with 1 μL of 20 mg/mL Proteinase K
for 3 to 4 h at 55 °C. Finally, the immunoprecipitated DNA was purified using
the Qiaquick PCR purification kit (Qiagen, 28104) according to manufac-
turer’s instructions. Eluted DNA was placed at 95 °C for 10 min and prepared
for qPCR using the primers in SI Appendix, Table S2.
Immunoprecipitation. All protein immunoprecipitation was carried out using
nuclear extracts prepared from K562 cells. Cells were collected by centrifu-
gation for 3 min at 1,400 × g. The packed cell volume (PCV) was estimated,
and the pellet was incubated with 2/3 PCV of nuclear extraction 1 (NE1)
buffer [10 mMHepes (pH 8.0), 1.5 mMMgCl2, 10 mM KCL, 1 mM dithiothreitol
(DTT)] for 15 min on ice, with protease inhibitors. Cells were then passed
through a 23-gauge needle 4 to 5 times and microfuged at full speed for 30 s
to isolate nuclei. The supernatant was discarded and remaining pellet resus-
pended in one PCV of NE2 buffer [20 mM Hepes (pH 8.0), 1.5 mM MgCl2, 25%
(vol/vol) glycerol, 420 mM NaCl, 0.2 mM EDTA, 1 mM DTT, and 0.5 mM phe-
nylmethylsulfonyl fluoride (PMSF)] on ice for with regular stirring for 30 min,
with protease inhibitor mixture. Nuclear debris was pelleted by 5 min micro-
fuge at full speed. The supernatant (nuclear extract) was dialyzed against
buffer D [20 mM Hepes (pH 8.0), 100 mM KCl, 0.2 mM EDTA, 20% (vol/vol)
glycerol, and 0.5 mM DTT] for 2 h at 4 °C. Dialyzed samples were cleared by
centrifugation at 13,000 × g for 5 min at 4 °C and precleared by incubation
with 10 μL Protein G magnetic beads and appropriate IgG antibody for 1 to 2 h
at 4 °C. Following the preclear, samples were divided as necessary onto fresh
Protein G magnetic beads, IP buffer [20 mM Hepes (pH 8.0), 100 mM KCl,
0.2 mM EDTA, 20% (vol/vol) glycerol, 0.5 mMDTT, and 0.05% (vol/vol) Nonidet
P-40] and the appropriate antibody. Samples were rotated at 4 °C overnight.
Loats et al. PNAS | 9 of 11


























The magnetic beads were collected and washed three times in 1 mL IP buffer.
For Western blot, beads were resuspended in 10 μL 1× SDS loading buffer per
gel and incubated at 95 °C for 3 min before SDS-polyacrylamide gel electro-
phoresis (PAGE) and Western blotting.
Quantitative RT-PCR Analysis. Total RNA was prepared using the RNeasy kit
(Qiagen, 74104) and complementary DNA (cDNA) prepared using the Iscript
cDNA synthesis kit (Bio-Rad, 1708890). qPCR was performed using iQ SYBR
green master mix (Bio-Rad, 1725121) with samples run in triplicate on a Bio-
Rad Miniopticon system. Melt curve analysis was performed at the end of
each run. Data were collected using the BioRad-CFX Manager software
(Version 3). The relative abundance of each transcript was compared with
control GAPDH. Primers used to amplify cDNA are listed in SI Appendix,
Table S2.
Immunofluorescence. K562 cells grown in suspension culture were collected
via centrifugation at 1,400 × g for 3 min. Nuclei were isolated using the
Nuclei EZ Prep nuclei isolation kit (Sigma-Aldrich, NUC101-1KT). Nuclei were
fixed in 4% (vol/vol) paraformaldehyde and rotated at room temperature
for 15 min, then incubated with 50 mM NH4Cl for 15 min, rotated, then
washed three times in PBS. The nuclei were then incubated in blocking
buffer [2% (wt/vol) BSA, 0.25% (wt/vol) gelatin, 0.2% (wt/vol) glycine, and
0.2% (vol/vol) Triton X-100 in PBS] for 1 h, rotating at room temperature.
Primary antibody was diluted in PBS with 1% (wt/vol) BSA, 0.25% (wt/vol)
gelatin, and 0.2% (vol/vol) Triton X-100 and incubated for 1 h, rotating at
room temperature. Nuclei were washed three times with washing buffer
[0.2% (wt/vol) gelatin in PBS]. Fluorescent secondary antibody was then
applied for 45 min in the same buffer as the primary antibody, and samples
were rotated in the dark. Secondary antibodies were AlexaFluor anti-mouse
(594) antibody (Thermo Fisher, 35510) and AlexaFluor anti-rabbit (488) an-
tibody (a21206). Nuclei were washed three times in washing buffer before
10 min incubation with DAPI solution. Nuclei were resuspended in a mini-
mum volume of 1,4-diazabicyclo[2.2.2]-octane (DABCO) mounting media
(Sigma-Aldrich) to mount onto poly-lysine–coated slides. Samples were
viewed using a Leica SP5-II AOBS confocal laser scanning microscope at-
tached to a Leica DM I6000 inverted epifluorescence microscope with oil 63×
lens. Images were processed using ImageJ or Volocity 6.3 software.
Click Chemistry. K-562 and MCF7 cells were incubated in lipid-free media
(RPMI and DMEM, respectively) containing 10 μg/mL alkyne cholesterol
(Avanti, 700143) for 16 h. Samples were washed once in PBS and nuclei
obtained using the EZ Prep nuclei kit, then incubated with 50 μM Azide-
PEG3-biotin conjugate (Sigma-Aldrich, 762024) was dissolved in prewarmed
buffer A and added to samples. The click reaction was initiated via addition
of 2 mM CuBF4 in 2% (vol/vol) acetonitrile, and the reaction was left to
proceed at 43 °C for 30 min with gentle agitation. The nuclei were then
washed in buffer A and immediately used for preparation of nuclear extract
for immunoprecipitation (using streptavidin magnetic beads, Thermo Fisher,
88816), chromatin immunoprecipitation (Click-ChIP with streptavidin mag-
netic beads), or immunofluorescence (using Streptavidin Alexa Fluor 594
conjugate, Thermo Fisher, S32356).
Protein Production, Cholesterol Assay, and Cholesterol-Binding Assay. For
production of BASP1 proteins, BL21 DE3 cells were initially transformed with
pRSF-1-NMT (Addgene, 42578) for the expression of NMT, then with the
pET23d BASP1 expression vectors. 20 mL of culture in Luria Broth (LB) me-
dium was seeded overnight at 37 °C, then added to 200 mL of media and
incubated for 1 h in a shaker at 37 °C. When required, myristic acid was
added to a final concentration of 0.2 mg/mL The optical density (at 600 nm
[OD600]) was monitored, and when OD600 = 0.6, isopropyl ß-D-1-thio-
galactopyranoside (IPTG) (1 mM) was added. After incubation at 37 °C for 3
h, the cells were harvested, and the pellet was frozen at −80 °C. The His-
tagged BASP1 derivatives were prepared using Ni-nitriloacetic acid (NTA)
beads following the manufacturer’s instructions (Qiagen, 30210). Purified
proteins were dialyzed into buffer D and stored at −80 °C.
Cholesterol was solubilized in methanol/chloroform/water (2:1:0.8 vol/vol/
v) at a final concentration of 1 mM, diluted as required, and dotted onto
polyvinylidene difluoride (PVDF)membrane. Themembranewas incubated in
binding buffer [20 mM Tris (pH 8), 300 mM NaCl, 0.5% (vol/vol) Tween, and
2.5% (wt/vol) dried milk] for 1 h rocking at room temperature. Fresh binding
buffer was added containing the BASP1 derivative at a concentration of
50 ng/μL and incubation continued for 1 h. The membrane was washed three
times for 10 min each with binding buffer. The membrane was then incu-
bated with binding buffer containing rabbit anti-BASP1 antibody for 30 min
then washed three times for 5 min each. The membrane was then incubated
with binding buffer containing anti-rabbit horse radish peroxidase (HRP) for
30 min, then washed three times for 5 min each and subjected to chem-
iluminescence. Cholesterol content of nuclear extracts was measured using
an Amplex Red cholesterol assay kit (Invitrogen, A12216).
Calcium Imaging. K562 cell line derivatives were grown on coverslips for
imaging. Cells were loaded with 2 μM fura2/AM with Pluronic F-127 for
40 min in Tyrode’s solution [140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 3 mM
CaCl2, 10 mM Hepes, 10 mM glucose, and 1 mM pyruvic acid (pH 7.4)] and
then imaged with an Olympus IX71 microscope. Excitation wavelengths of
340 nm and 380 nm were used with an emission wavelength of 510 nm.
Images were collected every 4 s using Imaging Workbench 5.2 (Indec Bio-
systems). Cells were perfused with Tyrode’s solution and stimulated with
10 mM ATP. Imaging data were collected as a ratio of fluorescence inten-
sities. An evoked response was defined as an increase in fluorescence that
was greater than 2 SD values above baseline.
Quantification and Statistical Analysis. Data are expressed as mean with SD
(SDM). Data distribution and significance between different groups was
analyzed in Excel or OriginPro 7.5 using Student’s t test. Calcium imaging
data were graphed without any filtering using OriginPro 7.5 software, and
statistical comparisons were made using a Fisher’s exact test. Autoradio-
graphs were quantitated using Image J (39).
Data Availability.All study data are included in the article and/or SI Appendix.
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